1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Antibiotics Market – By Drug Class

1.3.2        North America Antibiotics Market – By Action Mechanism

1.3.3        North America Antibiotics Market – By Country

2.           North America Antibiotics Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Antibiotics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Antibiotics Market - North America PEST Analysis

4.3         Expert Opinion

5.           North America Antibiotics Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Rising Prevalence of Bacterial Infections

5.1.2        Increasing Development of Generic Drugs

5.2         Key Market Restraints

5.2.1        Tedious and Expensive Process of Antibiotic Development

5.3         Market Opportunities

5.3.1        Growing Investments to Combat Antimicrobial Resistance

5.4         Future Trends

5.4.1        Incorporation of Novel Computing Technologies for Antibiotics Discovery

5.5         Impact analysis

6.           Antibiotics Market – North America Analysis

6.1         North America Antibiotics Market Revenue Forecasts and Analysis

7.           North America Antibiotics Market Analysis And Forecasts To 2027 – By Drug Class

7.1         Overview

7.2         North America Antibiotics market, By Drug Class 2019 & 2027 (%)

7.2.1        North America Antibiotics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

7.3         Sulfonamides

7.3.1        Overview

7.3.2        North America Sulfonamides Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Aminoglycosides

7.4.1        Overview

7.4.2        North America Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Carbapenem

7.5.1        Overview

7.5.2        North America Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Macrolides

7.6.1        Overview

7.6.2        North America Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Fluoroquinolones

7.7.1        Overview

7.7.2        North America Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)

7.8         Penicillin

7.8.1        Overview

7.8.2        North America Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)

7.9         Cephalosporins

7.9.1        Overview

7.9.2        North America Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)

7.10      Others

7.10.1     Overview

7.10.2     North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           North America Antibiotics Market Analysis –  By Action Mechanism

8.1         Overview

8.2         North America Antibiotics Market, By Action Mechanism 2019-2027 (%)

8.2.1        North America Antibiotics Market Revenue and Forecasts to 2027, By Action Mechanism (US$ Mn)

8.3         Mycolic Acid Inhibitors

8.3.1        Overview

8.3.2        North America Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         RNA Synthesis Inhibitors

8.4.1        Overview

8.4.2        North America RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         DNA Synthesis Inhibitors

8.5.1        Overview

8.5.2        North America DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Protein Synthesis Inhibitors

8.6.1        Overview

8.6.2        North America Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Cell Wall Synthesis Inhibitors

8.7.1        Overview

8.7.2        North America Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Others

8.8.1        Overview

8.8.2        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Antibiotics Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         North America Antibiotics Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        North America: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)

9.1.4        North America: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)

9.1.5        North America: Antibiotics Market, by Country, 2019 & 2027 (%)

9.1.6        US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          US: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)

9.1.6.3          US: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)

9.1.7        Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Canada: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)

9.1.7.3          Canada: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)

9.1.8        Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Mexico: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)

9.1.8.3          Mexico: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)

10.        Impact of COVID-19 Pandemic on North America Antibiotics Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Pfizer Inc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Johnson & Johnson Services, Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Bristol-Myers Squibb Company

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Eli Lilly and Company.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Abbott

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Word Index

LIST OF TABLES

Table 1.             North America Antibiotics Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)

Table 2.             North America Antibiotics Market Revenue and Forecasts To 2027, By Action Mechanism (US$ Mn)

Table 3.             North America Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)

Table 5.             US Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 6.             US Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)

Table 7.             Canada Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)

Table 9.             Mexico Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          Mexico Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)

Table 11.          List of Abbreviation

LIST OF FIGURES

Figure 1.           Antibiotics Market Segmentation

Figure 2.           North America Antibiotics Market Overview

Figure 3.           Cephalosporin Segment Held Largest Share of Product in Antibiotics Market

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Antibiotics Market - Leading Country Markets (US$ Mn)

Figure 6.           Antibiotics Market - North America PEST Analysis

Figure 7.           Antibiotics market impact analysis of driver and restraints

Figure 8.           North America Antibiotics market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           North America Antibiotics market, By Drug Class 2019 & 2027 (%)

Figure 10.        North America Sulfonamides Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        North America Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        North America Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        North America Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        North America Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        North America Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        North America Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        North America Antibiotics Market, by Action Mechanism 2019 & 2027 (%)

Figure 19.        North America Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        North America RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        North America DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        North America Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        North America Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        North America: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)

Figure 26.        North America Antibiotics Market Revenue and Forecast to 2027 (USD Million)

Figure 27.        North America: Antibiotics Market, by Country, 2019 & 2027 (%)

Figure 28.        US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Impact of Covid-19 Pandemic In North American Country Markets